Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology - 1 May 2010

Tiwari Arun K, Zai Clement C, Likhodi Olga, Lisker Annika, Singh Deepika, Souza Renan P, Batra Poonam, Zaidi Syed H E, Chen Sheng, Liu Fang, Puls Imke, Meltzer Herbert Y, Lieberman Jeffrey A, Kennedy James L, Müller Daniel J

Abstract excerpt

Antipsychotic-induced weight gain has emerged as a serious complication in the treatment of patients with atypical antipsychotic drugs. The cannabinoid receptor 1 (CNR1) is expressed centrally in the hypothalamic region and associated with appetite and satiety, as well as peripherally. An antagon...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Aryl Hydrocarbon Receptor Nuclear Translocator

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Obesity

Share to Protein Binding

Share to Receptor, Cannabinoid, CB1

Share to Weight Gain

Share to White People

Source

Open in PubMed Open full text

Identifiers

PMID: 20107430
DOI: 10.1038/npp.2009.235
PMCID: PMC3055343

Genes

CNR1
ARNT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20107430-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia.PMID 20107430Read ↗

Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain.Semantic proximity Read ↗

Cannabinoid type 1 receptor gene polymorphisms are not associated with olanzapine-induced weight gain.Semantic proximity Read ↗

Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed.Semantic proximity Read ↗

Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene.Semantic proximity Read ↗

Association of the common MC4R rs17782313 polymorphism with antipsychotic-related weight gain.Semantic proximity Read ↗

Genetics of antipsychotic-induced weight gain: update and current perspectives.Semantic proximity Read ↗

Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.Semantic proximity Read ↗

Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.Semantic proximity Read ↗

Pharmacogenetic Aspects of Antipsychotic Drug-induced Weight Gain - A Critical ReviewSemantic proximity Read ↗

Genetics of antipsychotic treatment emergent weight gain in schizophrenia.Semantic proximity Read ↗

Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients.Semantic proximity Read ↗

Olanzapine-induced weight gain is associated with the -759C/T and -697G/C polymorphisms of the HTR2C gene.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.